According to the official public account of Bailin Science on November 11, recently, Bailin Science Medical Technology (Shanghai) Co., Ltd. (referred to as "Bailin Science") announced the successful completion of a new round of global strategic financing, with a total financing amount reaching hundreds of million yuan. This round of financing was led by Kaihui Fund, with participation from Yahui Investment, Haihe Bailin Science Industry Fund, Shenchuang Investment, Haiwang Capital, and Wanwu Ventures among many other institutional investors. This financing will provide important financial support for Bailin Science's market expansion and product research and development, further accelerating the company's domestic and international market layout and technological innovation iterations.